Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals

Abstract Regulatory authorities must balance ensuring evidence of efficacy and safety of new drugs. Various regulatory pathways, such as the accelerated approval program in the United States (US), allow authorities to quickly approve drugs for severely ill patients by granting market authorization b...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hayase Hakariya (Autor), Frank Moriarty (Autor), Akihiko Ozaki (Autor), Shai Mulinari (Autor), Hiroaki Saito (Autor), Tetsuya Tanimoto (Autor)
Format: Knjiga
Izdano: Wiley, 2024-07-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno